Badée J, Fowler S, De Wildt SN et al (2019) The ontogeny of UDP-glucuronosyltransferase enzymes, recommendations for future profiling studies and application through physiologically based pharmacokinetic modelling. Clin Pharmacokinet 58:189–211. https://doi.org/10.1007/s40262-018-0681-2

Article  CAS  PubMed  Google Scholar 

Basit A, Neradugomma NK, Wolford C et al (2020) Characterization of differential tissue abundance of major non-CYP enzymes in human. Mol Pharm 17:4114–4124. https://doi.org/10.1021/acs.molpharmaceut.0c00559

Article  CAS  PubMed  Google Scholar 

Birnefeld J, Petersson K, Wåhlin A et al (2024) Cerebral blood flow assessed with phase-contrast magnetic resonance imaging during blood pressure changes with noradrenaline and labetalol: a trial in healthy volunteers. Anesthesiology 140:669–678. https://doi.org/10.1097/ALN.0000000000004775

Article  CAS  PubMed  Google Scholar 

Cho H-J, Kim J-E, Kim D-D, Yoon I-S (2014) In vitro–in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications. Drug Dev Ind Pharm 40:989–998. https://doi.org/10.3109/03639045.2013.831439

Article  CAS  PubMed  Google Scholar 

Dinis-Oliveira RJ (2017) Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance. Drug Metab Rev 49:84–91. https://doi.org/10.1080/03602532.2016.1278228

Article  CAS  PubMed  Google Scholar 

Fagerberg L, Hallström BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13:397–406. https://doi.org/10.1074/mcp.M113.035600

Article  CAS  PubMed  Google Scholar 

Halpern JH (2004) Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther 102:131–138. https://doi.org/10.1016/j.pharmthera.2004.03.003

Article  CAS  PubMed  Google Scholar 

Han D-G, Kwak J, Choi E et al (2023) Physicochemical characterization and phase II metabolic profiling of echinochrome A, a bioactive constituent from sea urchin, and its physiologically based pharmacokinetic modeling in rats and humans. Biomed Pharmacother 162:114589. https://doi.org/10.1016/j.biopha.2023.114589

Article  CAS  PubMed  Google Scholar 

Hasler F, Bourquin D, Brenneisen R et al (1997) Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv 72:175–184. https://doi.org/10.1016/S0031-6865(97)00014-9

Article  CAS  PubMed  Google Scholar 

Holze F, Becker AM, Kolaczynska KE et al (2023) Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants. Clin Pharmacol Ther 113:822–831. https://doi.org/10.1002/cpt.2821

Article  CAS  PubMed  Google Scholar 

Holzmann PP (1995) Bestimmung von psilocybin-metaboliten im humanplasma und-urin. Dissertation, University of Tübingen

Houston JB, Galetin A (2008) Methods for predicting in vivo pharmacokinetics using data from in vitro assays. Curr Drug Metab 9:940–951. https://doi.org/10.2174/138920008786485164

Article  CAS  PubMed  Google Scholar 

Ito K, Houston JB (2005) Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharm Res 22:103–112. https://doi.org/10.1007/s11095-004-9015-1

Article  CAS  PubMed  Google Scholar 

Izat N, Bolleddula J, Abbasi A et al (2023) Challenges and opportunities for in vitro–in vivo extrapolation of aldehyde oxidase-mediated clearance: toward a roadmap for quantitative translation. Drug Metab Dispos 51:1591–1606. https://doi.org/10.1124/dmd.123.001436

Article  CAS  PubMed  Google Scholar 

Leider M (1949) On the Weight of the skin**from the New York Skin and Cancer Unit, Department of Dermatology and Syphilology (Marion B. Sulzberger, M.D. Director) and the Post Graduate Medical School of the New York University-Bellevue Medical Center. J Invest Dermatol 12:187–191. https://doi.org/10.1038/jid.1949.28

Article  CAS  PubMed  Google Scholar 

Manevski N, Kurkela M, Höglund C et al (2010) Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos 38:386–395. https://doi.org/10.1124/dmd.109.031138

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molina DK, DiMaio VJM (2012a) Normal organ weights in men: part II—the brain, lungs, liver, spleen, and kidneys. Am J Forensic Med Pathol 33:368. https://doi.org/10.1097/PAF.0b013e31823d29ad

Article  PubMed  Google Scholar 

Molina DK, DiMaio VJM (2012b) Normal organ weights in men: part I-the heart. Am J Forensic Med Pathol 33:362–367. https://doi.org/10.1097/PAF.0b013e31823d298b

Article  PubMed  Google Scholar 

Nutt D (2019) Psychedelic drugs—a new era in psychiatry? Dialogues Clin Neurosci 21:139–147. https://doi.org/10.31887/DCNS.2019.21.2/dnutt

Article  PubMed  PubMed Central  Google Scholar 

Paine MF, Khalighi M, Fisher JM et al (1997) Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 283:1552–1562

CAS  PubMed  Google Scholar 

Pankow BG, Michalak J, McGee MK (1985) Adult human thyroid weight. Health Phys 49:1097

Article  CAS  PubMed  Google Scholar 

Passie T, Seifert J, Schneider U, Emrich HM (2002) The pharmacology of psilocybin. Addict Biol 7:357–364. https://doi.org/10.1080/1355621021000005937

Article  CAS  PubMed  Google Scholar 

Pöstges T, Lehr M (2023) Metabolism of sumatriptan revisited. Pharmacol Res Perspect 11:e01051. https://doi.org/10.1002/prp2.1051

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramanathan T, Skinner H (2005) Coronary blood flow. Contin Educ Anaesth Crit Care Pain 5:61–64. https://doi.org/10.1093/bjaceaccp/mki012

Article  Google Scholar 

Schraml C, Müssig K, Martirosian P et al (2009) Autoimmune thyroid disease: arterial spin-labeling perfusion MR imaging. Radiology 253:435–442. https://doi.org/10.1148/radiol.2533090166

Article  PubMed  Google Scholar 

Scotcher D, Billington S, Brown J et al (2017) Microsomal and cytosolic scaling factors in dog and human kidney cortex and application for in vitro-in vivo extrapolation of renal metabolic clearance. Drug Metab Dispos 45:556–568. https://doi.org/10.1124/dmd.117.075242

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sellers E (2017) Psilocybin: good trip or bad trip. Clin Pharmacol Ther 102:580–584. https://doi.org/10.1002/cpt.697

Article  CAS  PubMed  Google Scholar 

Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197–217. https://doi.org/10.1146/annurev.neuro.22.1.197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sia CH, Wang Z, Goh EML et al (2021) Urinary metabolite biomarkers for the detection of synthetic cannabinoid ADB-BUTINACA abuse. Clin Chem 67:1534–1544. https://doi.org/10.1093/clinchem/hvab134

Article  PubMed  Google Scholar 

Thomann J, Kolaczynska KE, Stoeckmann OV et al (2024) In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin. Front Pharmacol. https://doi.org/10.3389/fphar.2024.1391689

Article  PubMed